• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-07-09

  The referenced study reveals that naturally occurring angiotensin peptides, including truncated forms such as Angiotensin III, significantly enhance the binding of the SARS-CoV-2 spike protein to the alternative host receptor AXL. This finding uncovers a mechanistic intersection between the renin-angiotensin system and COVID-19 pathogenesis, with implications for cardiovascular and antiviral research.

• Cholecystokinin Octapeptide Ammonium: Immunoregulatory Mecha

  2026-07-08

  Explore the immunomodulatory and mechanistic depth of Cholecystokinin octapeptide ammonium (CCK-8 ammonium) in B cell and neurobehavioral research. This article uniquely bridges molecular insights with practical assay design, setting it apart from existing scenario- and protocol-driven content.

• Annexin V-Cy5/DAPI Apoptosis Kit: Precision Detection Unveil

  2026-07-08

  The Annexin V-Cy5/DAPI Apoptosis Kit enables rapid, high-sensitivity detection and differentiation of apoptotic and necrotic cells. Its use of Cy5-labeled Annexin V and DAPI supports robust, reproducible results in flow cytometry and microscopy. This apoptosis detection kit is validated for translational research and mechanistic studies of programmed cell death.

• IGF2BP1-m6A-TUBB4B Axis Drives Hepatic Stellate Cell Activat

  2026-07-07

  This study identifies the m6A reader IGF2BP1 as a pivotal regulator of hepatic stellate cell (HSC) activation and liver fibrosis. By stabilizing TUBB4B mRNA in an m6A-dependent manner, IGF2BP1 promotes HSC proliferation and fibrogenic signaling, highlighting a new molecular target for antifibrotic research.

• Advancing In Vitro Assessment of Anti-Angiogenic Cancer Drug

  2026-07-07

  Schwartz's dissertation introduces a rigorous framework distinguishing drug-induced proliferation arrest from cell death in vitro, revealing that anti-angiogenic agents like Tivozanib impact these processes with distinct kinetics and proportions. This approach enhances the resolution of drug response evaluation, informing translational oncology research and future experimental design.

• Cy5 Goat Anti-Rabbit IgG (H+L) Antibody: Workflow Precision

  2026-07-06

  The Cy5 Goat Anti-Rabbit IgG (H+L) Antibody enables high-sensitivity detection across immunofluorescence, IHC, and related assays, delivering robust signal amplification and minimal background. This guide translates advanced antiviral signaling research into actionable protocols, troubleshooting, and optimization strategies for researchers seeking reliable, quantitative results.

• CHIR-99021 (CT99021): Strategic GSK-3 Inhibition in Translat

  2026-07-06

  Explore the mechanistic depth and translational edge of CHIR-99021 (CT99021) for precise Wnt/β-catenin pathway modulation, pluripotency maintenance, and differentiation workflows. Integrating new insights from semaphorin receptor crosstalk, this article equips translational researchers with strategic guidance and protocol clarity—setting a new benchmark in stem cell and disease modeling applications.

• Dacarbazine: Precision Assay Design for Modern Chemotherapy

  2026-07-05

  Explore advanced, evidence-based strategies for integrating Dacarbazine as an antineoplastic chemotherapy drug in experimental workflows. Discover how new in vitro evaluation paradigms and mechanistic insights enable deeper, more reproducible cancer research.

• Precision Apoptosis Detection in Ph+ ALL: Next-Gen Insights

  2026-07-04

  Explore how the Annexin V-Cy5/DAPI Apoptosis Kit by APExBIO advances mechanistic and translational research in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). This article bridges the latest mechanistic discoveries on P2RX1-driven mitochondrial apoptosis with cutting-edge apoptosis detection strategies, providing strategic guidance for translational investigators.

• 5-Azacytidine Triggers ATR-Dependent Apoptosis in Myeloma Ce

  2026-07-03

  The referenced study establishes 5-Azacytidine as a DNA methyltransferase inhibitor that induces ATR-mediated DNA damage responses and apoptosis in both therapy-sensitive and resistant multiple myeloma cells. The results highlight synergistic cytotoxicity with doxorubicin and bortezomib, supporting further clinical exploration of these combinations.

• EZ Cap™ Firefly Luciferase mRNA: Enhanced Reporter Assays

  2026-07-03

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure unlocks robust, reproducible gene regulation and mRNA delivery workflows. Its advanced capping and poly(A) design yield sustained, high-sensitivity bioluminescent readouts for in vitro and in vivo applications.

• Superoxide Dismutase (SOD) Activity Assay Kit: Technical Gui

  2026-07-02

  The Superoxide Dismutase (SOD) Activity Assay Kit (SKU: K2035) enables precise, quantitative detection of SOD enzyme activity in biological fluids using a rapid, colorimetric workflow. It is best suited for oxidative stress and antioxidative enzyme research, not for diagnostic or clinical decision-making. Researchers should be aware of its sample-type boundaries and requirement for careful workflow setup.

• ZCL278: Selective Cdc42 Inhibitor for Cell Motility & Signal

  2026-07-02

  ZCL278 empowers precise interrogation of Cdc42-mediated signaling in models of cancer, neurobiology, and fibrosis, offering unique advantages for cell motility suppression and neuronal branching inhibition. This guide delivers actionable workflows, troubleshooting tactics, and cross-study insights to maximize data quality and reproducibility with this APExBIO-exclusive reagent.

• ECL Chemiluminescent Substrate Kit: Driving Translational Fe

  2026-07-01

  This thought-leadership article explores how the ECL Chemiluminescent Substrate Detection Kit empowers translational researchers to unravel drug resistance in clear cell renal cell carcinoma (ccRCC) by enabling ultrasensitive protein and nucleic acid detection. By weaving together mechanistic insights on ferroptosis, the latest evidence from TRIB3 knockdown studies, and best-practice protocol guidance, we highlight the strategic role of chemiluminescent detection in bridging bench discoveries and clinical innovation, while positioning APExBIO as a trusted partner in advanced oncological research.

• Cyanine 3 Tyramide: Illuminating Neural Circuits in Early Li

  2026-07-01

  Explore how Cyanine 3 Tyramide empowers translational neuroscience by enabling ultra-sensitive mapping of oxytocin signaling disruptions after early life adversity—bridging mechanistic insight with workflow strategy for the next era of signal amplification.

10287 records 2/686 page Previous Next 12345 下5页 Last page